Search results for "ATAL"

showing 10 items of 10591 documents

Prenatal diagnosis and epidemiology of multicystic kidney dysplasia in Europe

2014

ObjectivesThe aim of this study is to describe the prenatal diagnosis and epidemiology of multicystic kidney dysplasia (MCKD). MethodsThe study is based on routinely collected data from a European database of major congenital anomalies including 13 registries with cases born in 1997-2006 and covering 1458552 births. ResultsThere were 601 MCKD cases giving an overall prevalence of 4.12 per 10000 births with regional variation. In live births, 87% of cases had an isolated renal anomaly and 13% had associated major nonrenal anomalies (chromosomal, syndrome or other major anomalies). For the cases with isolated renal anomalies, 51/386 (11%) and 7/386 (2%) choose to terminate the pregnancy or re…

medicine.medical_specialtyPediatricsPregnancyMulticystic Kidney DysplasiaFetal deathbusiness.industryObstetrics and GynecologyPrenatal diagnosismedicine.diseaseRenal anomalyEpidemiologyMedicineDetection ratebusinessGenetics (clinical)Prenatal Diagnosis
researchProduct

Outcome of pregnancy in type 1 diabetic patients treated with insulin lispro or regular insulin: an Italian experience.

2008

Some studies have shown that fetal outcome observed in patients using insulin lispro is much the same as in pregnant women using regular insulin. This study aims to analyze the Italian data emerging from a multinational, multicenter, retrospective study on mothers with type 1 diabetes mellitus before pregnancy, comparing those treated with insulin lispro for at least 3 months before and 3 months after conception with those treated with regular insulin. The data collected on pregnant women with diabetes attending 15 Italian centers from 1998 to 2001 included: HbA1c at conception and during the first and third trimesters, frequency of severe hypoglycemic episodes, spontaneous abortions, mode …

medicine.medical_specialtyPediatricsneonatal mortalityendocrine system diseasesEndocrinology Diabetes and MetabolismBirth weightEndocrinologyPregnancyInternal medicineDiabetes mellitusInternal MedicineBirth WeightHumansHypoglycemic AgentsInsulinMedicineInsulin lisproChromatography High Pressure LiquidRetrospective StudiesGlycated HemoglobinType 1 diabetesPregnancyInsulin Lisprodiabetesbusiness.industryInfant Newbornnutritional and metabolic diseasesRetrospective cohort studyGeneral Medicinemedicine.diseasediabetes; malformations; neonatal mortality; pregnancyPregnancy ComplicationsDiabetes Mellitus Type 1EndocrinologyItalyInfant Small for Gestational AgeRegular insulinmalformationsSmall for gestational ageFemalebusinessmedicine.drug
researchProduct

Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group-Italian Neurological Society

2011

Three years after the introduction of natalizumab (NA) therapy for the second line treatment of relapsing-remitting multiple sclerosis (MS), Italian MS centers critically reviewed the scientific literature and their own clinical experience. Natalizumab was shown to be highly efficacious in the treatment of MS. However, the risk of progressive multifocal leukoencephalopathy was confirmed and defined better. This article summarizes the MS-SIN Study Group recommendations on the use of NA in MS, with particular reference to the appropriate selection and monitoring of patients as well as to the management of adverse events.

medicine.medical_specialtyPediatricspml; iris; multiple sclerosis; natalizumabMultiple SclerosisNeurologypmlMEDLINEProgressive MultifocalDermatologyRelapsing-RemittingAntibodies Monoclonal HumanizedAntibodiesLeukoencephalopathyMultiple Sclerosis Relapsing-RemittingNatalizumabLeukoencephalopathyMonoclonalmedicineHumansAdverse effectAntibodies; Monoclonal; Humanized Antibodies; therapeutic use Humans Leukoencephalopathy; Progressive Multifocal; chemically induced Multiple Sclerosis; Relapsing-Remitting; drug therapyHumanizedMultiple sclerosis Natalizumab PML IRISirisbusiness.industryNatalizumabProgressive multifocal leukoencephalopathyMultiple sclerosisLeukoencephalopathy Progressive MultifocalAntibodies MonoclonalGeneral Medicinemedicine.diseasedrug therapyPsychiatry and Mental healththerapeutic usechemically inducednatalizumab multiple sclerosis treatment guidelinesPhysical therapySettore MED/26 - NeurologiaNeurology (clinical)Neurosurgerybusinessmedicine.drug
researchProduct

Long-term prediction of birth weight

1993

On the basis of the hypothesis that undisturbed individual growth in fetal life keeps a constant proportional difference with the standard population 50th percentile, birth weight can be predicted with a single sonographic exploration after the 16th week of pregnancy. Data on 135 singleton pregnancies with accurate dates and delivery at term were used. Sonography was performed between the 17th and 36th weeks of pregnancy, in every case at least 4 weeks before delivery. The observed measurements of BPD, FL, and AC were used for the prediction of their values on the day of delivery, applying the Hadlock equation for the estimation of birth weight. The mean error of birth weight predictions wa…

medicine.medical_specialtyPercentileCorrelation coefficientBirth weightUltrasonography PrenatalEmbryonic and Fetal DevelopmentPredictive Value of TestsPregnancymedicineBirth WeightHumansFalse Positive ReactionsRadiology Nuclear Medicine and imagingLongitudinal StudiesLong-term predictionFetusPregnancyRadiological and Ultrasound Technologybusiness.industryObstetricsSingletonReproducibility of ResultsGestational agemedicine.diseaseSurgeryFemalebusinessJournal of Ultrasound in Medicine
researchProduct

Ovarian cysts in the fetus and neonate--changes in sonographic pattern in the follow-up and their management.

1992

In a multicenter trial we retrospectively evaluated the clinical and sonographic data of 49 neonatal ovarian cysts, 44 of which were detected prenatally and 5 on the first day after delivery. Of the 44 prenatally detected cysts 39 were purely cystic, 5 echogenic or had a mixed pattern. In 20 patients the cystic appearance changed during delivery from purely cystic to a mixed pattern being independent on the size of the cyst. 26 of the 44 cysts were treated surgically. Salpingotorsion was found in 8 and was independent on the size of the cyst. In 15 a salpingo-oophorectomy or oophorectomy was performed, in 11 the ovary was saved. 23 patients were followed sonographically: 15 cysts showed com…

medicine.medical_specialtyPercutaneousmedicine.medical_treatmentOvaryUltrasonography PrenatalPregnancyMulticenter trialparasitic diseasesmedicineHumansRadiology Nuclear Medicine and imagingCystNeuroradiologyRetrospective StudiesPregnancybusiness.industryInfant NewbornOophorectomymedicine.diseaseSurgeryFetal DiseasesOvarian Cystsmedicine.anatomical_structureIn uteroPediatrics Perinatology and Child HealthFemalebusinessFollow-Up StudiesPediatric radiology
researchProduct

Clinical Efficacy of Laquinimod for the Treatment of Multiple Sclerosis; Pooled Analyses from the ALLEGRO and BRAVO Phase III Trials (S01.007)

2012

Objective: The current report provides detail on pooled analyses assessing the effect of laquinimod on relapse, disability, and brain atrophy measures from the recently completed phase III trials ALLEGRO and BRAVO. Background Laquinimod is an oral, CNS acting immunomodulator in development for the treatment of multiple sclerosis. Its impact on disability progression and brain atrophy, two indices of longterm outcome for patients with multiple sclerosis (MS) are being studied in its phase III trials. Design/Methods: MS patients (N=2437) were randomized to laquinimod (n=984) or placebo (n = 1006). In both trials, patients underwent neurological examinations including the Expanded Disability S…

medicine.medical_specialtyPhase iii trialsbusiness.industryRelapse ratePharmacologyClinical trialSafety profilechemistry.chemical_compoundchemistryFamily medicineMedicinemedia_common.cataloged_instanceDisability progressionNeurology (clinical)Clinical efficacyEuropean unionbusinessLaquinimodmedia_commonNeurology
researchProduct

Theoretical basis for the use of non-invasive thermal measurements to assess the brain injury in newborns undergoing therapeutic hypothermia.

2020

AbstractThe aim of this paper is to propose a new non-invasive methodology to estimate thermogenesis in newborns with perinatal asphyxia (PA) undergoing therapeutic hypothermia (TH). Metabolic heat production (with respect to either a neonate’s body mass or its body surface) is calculated from the newborn’s heat balance, estimating all remaining terms of this heat balance utilising results of only non-invasive thermal measurements. The measurement devices work with standard equipment used for therapeutic hypothermia and are equipped with the Global System for Mobile Communications (GSM), which allows one to record and monitor the course of the therapy remotely (using an internet browser) wi…

medicine.medical_specialtyPhysiologyScienceArticleBody Temperature03 medical and health sciences0302 clinical medicineHypothermia InducedmedicineHumansMultidisciplinaryHeat balancebusiness.industryNon invasiveQRInfant NewbornHealth care030208 emergency & critical care medicineHypothermiaModels Theoreticalmedicine.diseasePerinatal asphyxiaBrain InjuriesEmergency medicineMetabolic heat productionMedicinemedicine.symptombusiness030217 neurology & neurosurgeryAlgorithmsScientific reports
researchProduct

Early, but not late onset estrogen replacement therapy prevents oxidative stress and metabolic alterations caused by ovariectomy.

2014

Aims: The usefulness of estrogen replacement therapy (ERT) in preventing oxidative stress associated with menopause is controversial. We aimed to study if there is a critical time window for effective treatment of the effects of ovariectomy with estrogens at the molecular, metabolic, and cellular level. Results: Our main finding is that early, but not late onset of ERT prevents an ovariectomy-associated increase in mitochondrial hydrogen peroxide levels, oxidative damage to lipids and proteins, and a decrease in glutathione peroxidase and catalase activity in rats. This may be due to a change in the estrogen receptor (ER) expression profile: ovariectomy increases the ER α/β ratio and immedi…

medicine.medical_specialtyPhysiologymedicine.drug_classGlucose uptakeOvariectomyClinical BiochemistryGlucose Transport Proteins FacilitativeEstrogen receptorMitochondria LiverBiologymedicine.disease_causeBiochemistryAntioxidantsInternal medicinemedicineAnimalsMetabolomicsMolecular BiologyGeneral Environmental Sciencechemistry.chemical_classificationEstradiolGlutathione peroxidaseEstrogen Replacement TherapyGlucose transporterBrainCell BiologyHydrogen Peroxidemedicine.diseaseRatsMenopauseOxidative StressOriginal Research CommunicationsEndocrinologyGlucosechemistryEstrogenCatalasebiology.proteinGeneral Earth and Planetary SciencesFemaleOxidative stressAntioxidantsredox signaling
researchProduct

Low target birth weight or growth retardation? Umbilical Doppler flow velocity waveforms and histometric analysis of fetoplacental vascular tree

1993

Objective: The placental vascular architecture of small-for-gestatonal-age fetuses seems to have an impact on the flow patterns in the umbilical arteries. Study Design: Blood flow velocity waveforms of the umbilical arteries were measured by Doppler ultrasonography in nine small-for-gestational-age fetuses with elevated systolic/diastolic ratios of the umbilical arteries, seven small-for-gestational-age fetuses with normal flow patterns, and 14 appropriate-for-gestational-age fetuses with normal flow patterns. After delivery histomorphometric placental investigations were performed. Results: Reduced end-diastolic flow velocities were significantly associated with both a reduction of vascula…

medicine.medical_specialtyPlacentaDiastoleHemodynamicsUltrasonography PrenatalUmbilical ArteriesPregnancymedicine.arteryInternal medicinePlacentamedicineHumansFetusFetal Growth Retardationbusiness.industryInfant NewbornObstetrics and GynecologyUmbilical arteryBlood flowInfant Low Birth WeightVelocimetrySurgerymedicine.anatomical_structureembryonic structuresCardiologyFemalebusinessPerfusionBlood Flow VelocityAmerican Journal of Obstetrics and Gynecology
researchProduct

Treatment of congenital abdominal wall defects —a 25-year review of 132 patients

2013

The outcome data of 132 patients treated at the Department of Pediatric Surgery in Mainz during the last 25 years were reviewed. Prenatal diagnosis of abdominal wall defects (AWDs) and associated malformations led to increasing selection of the patient population. The aim of primary closure of the abdominal wall can be achieved more frequently in gastroschisis (GS) than omphalocele (OC), while the postoperative course is more complicated and of longer duration in GS. Delayed or secondary closure extended the hospitalization period but had no negative effects on the outcome. Reoperations or planned secondary operations were performed in 23 patients with GS and 14 with OC. Early mortality was…

medicine.medical_specialtyPregnancyOmphaloceleGastroschisisbusiness.industryPrenatal diagnosisGeneral Medicinemedicine.diseaseSurgeryAbdominal wallmedicine.anatomical_structureQuality of lifePediatrics Perinatology and Child HealthPediatric surgerymedicineSurgeryComplicationbusinessPediatric Surgery International
researchProduct